Publications by authors named "Eiji Takeuchi"

Claim this Profile
S
Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature review.
Yugo Matsumura, Seiya Ichihara, Kaori Nii, Naoki Kadota, Yoshio Okano, Eiji Takeuchi

Medicine (Baltimore)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary cavitary disease due to Mycobacterium intracellulare cured in a healthy young adult leaving only calcifications.
Hiroki Takahashi, Yuko Toyoda, Eiji Takeuchi, Tsutomu Shinohara

Int J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.
Yugo Matsumura, Seiya Ichihara, Kaori Nii, Kazumasa Nanjo, Naoki Kadota, Eiji Takeuchi

Thorac Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.
Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, Soji Kakiuchi, Shoko Harada, Eiji Takeuchi

Int J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano, Seiya Ichihara

Thorac Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations.
Michihiro Kunishige, Eiji Takeuchi

Thorac Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.
Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu

Thorac Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suspected Aspergillus nodule histologically consistent with pulmonary nodular lymphoid hyperplasia:a case report.
Shun Morizumi, Atsushi Morishita, Miho Nishiyama, Kiyohide Takahashi, Kenya Sumitomo, Eiji Takeuchi

J Med Invest· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige

Thorac Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary Ground-Glass Nodule Mimicking Lung Cancer due to Focal Progression of Usual Interstitial Pneumonia.
Hiroyuki Hino, Shizuka Shinohara, Yoshio Okano, Keishi Naruse, Eiji Takeuchi

Int J Surg Pathol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer.
Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Michihiro Kunishige, Yoshihiro Kondo

J Cancer Res Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib.
Michihiro Kunishige, Seiya Ichihara, Naoki Kadota, Yoshio Okano, Hisanori Machida, Eiji Takeuchi

Thorac Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer.
Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Yoshio Okano, Hisanori Machida, Eiji Takeuchi

Thorac Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small-cell carcinoma: A case report.
Junki Terada, Yuko Toyoda, Eiji Takeuchi, Nobuyuki Tanida, Satoshi Ito

Thorac Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab.
Naoki Kadota, Nobuo Hatakeyama, Hiroyuki Hino, Michihiro Kunishige, Yoshihiro Kondo, Eiji Takeuchi

Cancer Rep (Hoboken)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive eosinophilia despite severe aplastic anemia.
Aya Takahashi, Yoshihito Iwahara, Hisanori Machida, Keishi Naruse, Eiji Takeuchi

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer.
Yoshio Okano, Atsushi Morishita, Keishi Naruse, Eiji Takeuchi

Intern Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type A thymoma: a rare cause of neoplastic cardiac tamponade with long-term survival.
Mika Takashima, Kozo Kagawa, Toru Sawada, Hiroyuki Hino, Keishi Naruse, Eiji Takeuchi

BMC Pulm Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
Eiji Takeuchi, Yoshio Okano, Hisanori Machida, Katsuhiro Atagi, Yoshihiro Kondou

Cancer Immunol Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient.
Yoshio Okano, Michihiro Kunishige, Yoshihiro Kondo, Naoki Kadota, Atsushi Morishita, Eiji Takeuchi

Thorac Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer.
Yoshihiro Kondo, Michihiro Kunishige, Naoki Kadota, Yoshio Okano, Hisanori Machida, Eiji Takeuchi

Thorac Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary mycobacteriosis caused by Mycobacterium peregrinum: A case report.
Yutaka Morita, Yoshihiro Kondo, Eiji Takeuchi

Medicine (Baltimore)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report.
Eiji Takeuchi, Yuri Okamoto, Naoki Takahashi, Shun Morizumi, Yuko Toyoda

Thorac Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-5-producing malignant pleural mesothelioma with eosinophilic pleural effusion.
Eiji Takeuchi, Naoki Takahashi, Shun Morizumi, Hiroyuki Tamiya, Hisashi Matsuoka

Thorac Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of extensive bowel resection without intestinal continuity: a case report.
Koichi Mohri, Eiji Takeuchi, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka

Nagoya J Med Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis